Previous close | 5.60 |
Open | 5.40 |
Bid | 5.65 x 0 |
Ask | 6.00 x 0 |
Day's range | 5.40 - 5.60 |
52-week range | 1.58 - 7.35 |
Volume | |
Avg. volume | 5 |
Market cap | N/A |
Beta (5Y monthly) | N/A |
PE ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings date | 29 Feb 2024 - 04 Mar 2024 |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
BRIDGEWATER, N.J., April 24, 2024--Amneal Announces U.S. FDA Approval of Over-the-Counter Naloxone Hydrochloride Nasal Spray for Emergency Treatment of an Opioid Overdose
BRIDGEWATER, N.J., April 16, 2024--Amneal Launches PEMRYDI RTU®, the First Ready-to-Use Version of Important Oncology Injectable Medicine
When you buy shares in a company, there is always a risk that the price drops to zero. On the other hand, if you find a...